Literature DB >> 21780848

The non-surgical and surgical treatment of tarsal navicular stress fractures.

John R Fowler1, John P Gaughan, Barry P Boden, Helene Pavlov, Joseph S Torg.   

Abstract

Stress fractures of the tarsal navicular, first described in 1970, were initially thought to be rare injuries. Heightened awareness and increased participation in athletics has resulted in more frequent diagnosis and more aggressive treatment. The vascular supply of the tarsal navicular results in a relatively avascular zone in the central one-third, which experiences severe compressive forces during explosive manoeuvers such as jumping and sprinting. Repetitive activities can result in stress reactions or even fracture. Patients often initially complain of vague midfoot pain localized to the medial border of the foot. The pain is usually exacerbated by activity and relieved with rest. The diagnosis of tarsal navicular stress fracture is challenging because of the high false negative rate of plain radiographs. Additional diagnostic testing with bone scan, CT and MRI are often required for diagnosis. The proper treatment of tarsal navicular stress fractures has become a topic of debate as surgical intervention for these injuries has increased. In a recent meta-analysis, Torg et al. found that 96% of tarsal navicular stress fractures treated with non-weight-bearing (NWB) conservative treatment for 5 weeks went on to successful outcomes. However, only 44% of patients treated with weight-bearing (WB) conservative treatment had successful outcomes. Surgical treatment resulted in successful outcome in 82% of patients. Interestingly, the meta-analysis also found that fracture type did not correlate with outcomes, regardless of treatment. The meta-analysis also found no difference in time to return to activity between patients treated surgically and those who underwent NWB conservative treatment. The recent literature indicates that patients are undergoing surgery or are receiving WB conservative management as a first-line treatment option with the expectation that they will return to their activity more quickly. Although surgical treatment seems increasingly common, the results statistically demonstrate an inferior trend to conservative NWB management. Conservative NWB management is the standard of care for initial treatment of both partial and complete stress fractures of the tarsal navicular. WB conservative treatment and surgical intervention are not recommended.

Entities:  

Mesh:

Year:  2011        PMID: 21780848     DOI: 10.2165/11590670-000000000-00000

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  27 in total

Review 1.  The anatomy of the navicular and periarticular structures.

Authors:  Pau Golano; Oscar Fariñas; Ivan Sáenz
Journal:  Foot Ankle Clin       Date:  2004-03       Impact factor: 1.653

2.  Bilateral stress fractures of the tarsal navicular with associated avascular necrosis in a pole vaulter.

Authors:  P E Helstad; J B Ringstrom; B B Erdmann; P M Jacobs; M E Julsrud
Journal:  J Am Podiatr Med Assoc       Date:  1996-11

3.  The incidence and distribution of stress fractures in competitive track and field athletes. A twelve-month prospective study.

Authors:  K L Bennell; S A Malcolm; S A Thomas; J D Wark; P D Brukner
Journal:  Am J Sports Med       Date:  1996 Mar-Apr       Impact factor: 6.202

4.  Navicular stress fractures: a prospective study on athletes.

Authors:  Amol Saxena; Brian Fullem
Journal:  Foot Ankle Int       Date:  2006-11       Impact factor: 2.827

5.  Stress fractures of the tarsal navicular. A retrospective review of twenty-one cases.

Authors:  J S Torg; H Pavlov; L H Cooley; M H Bryant; S P Arnoczky; J Bergfeld; L Y Hunter
Journal:  J Bone Joint Surg Am       Date:  1982-06       Impact factor: 5.284

6.  Results of treatment of 22 navicular stress fractures and a new proposed radiographic classification system.

Authors:  A Saxena; B Fullem; D Hannaford
Journal:  J Foot Ankle Surg       Date:  2000 Mar-Apr       Impact factor: 1.286

7.  Stress fractures: a review of 180 cases.

Authors:  P Brukner; C Bradshaw; K M Khan; S White; K Crossley
Journal:  Clin J Sport Med       Date:  1996-04       Impact factor: 3.638

8.  Tarsal navicular stress fracture in athletes.

Authors:  K M Khan; P D Brukner; C Kearney; P J Fuller; C J Bradshaw; Z S Kiss
Journal:  Sports Med       Date:  1994-01       Impact factor: 11.136

9.  Stress fractures of the tarsal navicular in long-distance runners.

Authors:  A Ting; W King; L Yocum; D Antonelli; D Moynes; R Kerlan; F Jobe; L Wong; J Bertolli
Journal:  Clin Sports Med       Date:  1988-01       Impact factor: 2.182

10.  Tarsal navicular stress fractures in runners.

Authors:  T G Goergen; E A Venn-Watson; D J Rossman; D Resnick; K H Gerber
Journal:  AJR Am J Roentgenol       Date:  1981-01       Impact factor: 3.959

View more
  4 in total

1.  Risk Factors for Reoperation and Performance-Based Outcomes After Operative Fixation of Foot Fractures in the Professional Athlete: A Cross-Sport Analysis.

Authors:  Sameer K Singh; Kevin E Larkin; Anish R Kadakia; Wellington K Hsu
Journal:  Sports Health       Date:  2017-09-15       Impact factor: 3.843

2.  Foot Kinematics Differ Between Runners With and Without a History of Navicular Stress Fractures.

Authors:  James Becker; Stanley James; Louis Osternig; Li-Shan Chou
Journal:  Orthop J Sports Med       Date:  2018-04-20

Review 3.  Return to sport following navicular stress fracture: a systematic review and meta-analysis of three hundred and fifteen fractures.

Authors:  Ahmed Khalil Attia; Karim Mahmoud; Jason Bariteau; Sameh A Labib; Christopher W DiGiovanni; Pieter D'Hooghe
Journal:  Int Orthop       Date:  2021-08-20       Impact factor: 3.075

4.  Treatment of Navicular Stress Fracture Accompanied by Os Supranaviculare: A Case Report.

Authors:  Woo-Jong Kim; Ki-Jin Jung; Eui-Dong Yeo; Hong-Seop Lee; Sung-Hun Won; Dhong-Won Lee; Jae-Young Ji; Sung-Joon Yoon; Yong-Cheol Hong
Journal:  Medicina (Kaunas)       Date:  2021-12-24       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.